Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

PRP therapy for hair loss is safe but its effectiveness is doubtful.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The new system helps detect and track early female hair loss better.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Raccoon dogs in Schleswig-Holstein, Germany, were found with sarcoptic mange, showing severe skin issues and potential for spreading the disease.

Finger length ratios might predict risk for skin condition in males.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Aromatase gene variation may increase female hair loss risk.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.